Recursion expands partnership with Citeline to enhance AI-driven clinical trial platform.

Recursion has expanded its strategic partnership with Citeline to integrate Citeline's real-world data and evidence capabilities into Recursion's AI-enabled ClinTech platform. This collaboration aims to improve clinical trial design, site selection, and development decisions, resulting in faster and more efficient drug development. The partnership has already shown benefits, including a 30-60% improvement in patient enrollment for ongoing studies. This move reflects a broader commitment to creating a more predictive, patient-centered biopharmaceutical ecosystem that accelerates the journey from drug discovery to patient treatment.